Jvion Continues Momentum in 2020 with Initiatives to Address COVID-19 Disparities, Expanded Product Offerings, and Industry Recognition
As the healthcare industry faces unprecedented pressure from COVID-19, revenue loss and deferred care, Jvion adapts its prescriptive clinical artificial intelligence (AI) to meet the moment
ATLANTA, GA – September 8, 2020: Jvion, a leader in clinical AI, has continued its momentum in 2020 with...
Jvion Lauded by Frost & Sullivan for Improving Patient Outcomes Using Its Clinical-AI CORE™ Intelligence Platform
Jvion’s prescriptive analytics approach identifies undetected risk and modifiable risk trajectories followed by recommendations for remedial actions
SANTA CLARA, Calif. — September 1, 2020 - Based on its recent analysis of the North American prescriptive analytics market, Frost & Sullivan r...
The University of Mississippi Medical Center (UMMC) recently extended the application of Jvion’s solution to broaden the system’s objectives of improving population health outcomes and driving down the cost of care.